Traditional Chinese medicine composition for treating irritable bowel syndrome and preparation method thereof

Abstract

The invention discloses a traditional Chinese medicine composition for treating an irritable bowel syndrome. The composition is characterized by being prepared from the following medicinal materials in parts by weight: 9 to 15 parts of radix bupleuri, 9 to 15 parts of Chinese parsnip root, 9 to 15 parts of schisandra chinensis, 12 to 18 parts of rhizoma atractylodis macrocephalae, 9 to 15 parts of pericarpium citri reticulatae, 18 to 22 parts of white paeony root, 18 to 22 parts of myristica fragrans, 18 to 22 parts of fructus psoraleae, 15 to 20 parts of codonopsis pilosula, 9 to 15 parts of baked ginger, 9 to 15 parts of poria cocos, 12 to 18 parts of rhizoma curculiginis, 6 to 12 parts of radix aucklandiae, 12 to 18 parts of piper cubeba, 6 to 12 parts of fructus foeniculi, 12 to 18 parts of immature bitter orange, 12 to 18 parts of pomegranate bark, 18 to 22 parts of red halloysite, 12 to 18 parts of Chinese yam, 6 to 12 parts of scorched hawthorn fruit, 12 to 18 parts of herba epimedii, 9 to 15 parts of cicada slough, 9 to 15 parts of the root of kudzu vine, 9 to 15 parts of rhizoma corydalis, 9 to 15 parts of the root of three-nerved spicebush, 9 to 15 parts of smoked plum, 9 to 15 parts of the root of Chinese pulsatilla, 9 to 15 parts of patrinia, 6 to 12 parts of the root of red-rooted salvia, 12 to 18 parts of astragalus membranaceus, 9 to 15 parts of baked radix aucklandiae, 9 to 15 parts of baked myrobalan and 6 to 12 parts of honey-fried licorice root. The clinical experiment proves that the composition can be used for safely and effectively treating the irritable bowel syndrome.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for treating irritable bowel syndrome and a preparation method thereof. Background technique [0002] Irritable bowel syndrome (IBS) is a group of continuous or intermittent episodes of intestinal dysfunction with clinical manifestations of abdominal pain, abdominal distension, changes in bowel habits and / or stool properties, but lack of structural and biochemical abnormalities in the gastrointestinal tract. Typical symptoms are abdominal pain and bloating associated with abnormal defecation. According to the main symptoms, it can be divided into: diarrhea-dominant type; constipation-dominant type; alternating diarrhea and constipation type. Currently, there is no recognized safe and effective drug for the treatment of irritable bowel syndrome. Contents of the invention [0003] The problem to be solved by the present inve...

AI Technical Summary

Problems solved by technology

There is still no recognized safe and effective treatment for irritable bowel syndrome